Loss of RasGAP Tumor Suppressors Underlies the Aggressive Nature of Luminal B Breast Cancers.

导出 OA

翻译打印收藏纠错

第一作者： Sarah Naomi,Olsen

第一单位： Genetics Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

作者： Sarah Naomi,Olsen ^[1] ; Ania,Wronski ^[2] ; Zafira,Castaño ^[3] ; Benjamin,Dake ^[4] ; Clare,Malone ^[2] ; Thomas,De Raedt ^[5] ; Miriam,Enos ^[3] ; Yoko S,DeRose ^[4] ; Wenhui,Zhou ^[1] ; Stephanie,Guerra ^[2] ; Massimo,Loda ^[1] ; Alana,Welm ^[2] ; Ann H,Partridge ^[1] ; Sandra S,McAllister ^[2] ; Charlotte,Kuperwasser ^[6] ; Karen,Cichowski ^[3]

作者单位： Genetics Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. ^[1] Harvard Medical School, Boston, Massachusetts. ^[2] Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts. ^[3] Department of Anatomy and Cellular Biology, Tufts University School of Medicine, Boston, Massachusetts. ^[4] Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Harvard Stem Cell Institute, Cambridge, Massachusetts. ^[5] Huntsman Cancer Institute, Salt Lake City, Utah. ^[6] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[7] Dana-Farber Cancer Institute, Boston, Massachusetts. ^[8] Genetics Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. kcichowski@rics.bwh.harvard.edu. ^[9]